全球內視鏡逆行性胰造影市場：市場規模、佔有率和趨勢分析（2025-2032 年）

預計2025年，全球內視鏡逆行性造影（ERCP）設備市場規模將超過19億美元。預計到2032年，該市場將以5.6%的複合年成長率成長，達到28億美元以上。

本報告涵蓋括約肌切開器、膽道結石取出球囊、膽道結石取出籃、膽道擴張球囊、膽道和胰管支架、膽道結石取出器、ERCP導管導引線和 ERCP 套管。

它量化了銷售量、平均售價、市值和成長率，並涵蓋了企業市場占有率、市場促進因素和影響因素、近期併購活動以及技術趨勢。分析包括2022年至2024年的歷史資料以及至2032年的預測資料。

這反映了醫療專業人員如何接受微創和治療性 ERCP 技術，以及持續的產品創新，特別是短導絲系統和管腔接近支架，如何提高手術效率和患者療效。

市場概覽

內視鏡逆行性造影（ERCP）是一種專門用於診斷和治療膽道和胰管疾病的內視鏡手術。 ERCP結合了內視鏡和透視影像技術，可以進行括約肌切開術、取石術和支架置入術等介入性治療。

過去十年間，隨著器材設計和技術的重大進步，ERCP 的角色已從主要作為診斷工具轉變為治療性介入。這種轉變擴大了 ERCP 器械的潛在市場，並使該領域成為微創胃腸道治療的基石。

市場發展主要受已開發地區和新興地區手術量增加的驅動。膽道阻塞、膽結石和胰臟炎在全球範圍內的發病率不斷上升，推動了對內視鏡逆行性胰膽管造影（ERCP）的需求。此外，人口老化和慢性肝病盛行率的上升也增加了手術頻率。

科技創新對提升醫師診療水準和降低併發症率產生了特別顯著的影響。短導絲系統的引入實現了更快的插管速度、更可靠的器械更換以及更有效率的工作流程。如今，許多大型醫療中心已將此類系統視為新的手術標準。

藥物釋放型支架和管腔貼合支架技術也擴展了 ERCP 的治療能力，使得在超音波內視鏡 (EUS) 引導下儲存胰臟積液和壁壞死等複雜適應症成為可能。

同時，某些領域，例如ERCP套管，正逐漸被更先進的器械類型（例如括約肌切開器）所取代，這限制了某些類別的成長。儘管存在這些內部變化，預計ERCP設備市場在未來十年仍將持續擴張。

市場促進因素

括約肌切開刀市場

治療性內視鏡逆行性胰膽管攝影術（ERCP）的興起是全球市場的主要成長動力。人們越來越重視治療而非診斷，這推動了對括約肌鏡的需求。該領域在ERCP設備市場中佔最大佔有率，預計將持續影響整體成長至2032年。

括約肌切開刀設計的進步，例如改進的導絲控制和與短導絲系統的兼容性，進一步推動了其應用。隨著醫院轉向使用一次性配件以降低感染風險，預計該類別對整體市場的貢獻將進一步增強。

短線系統

短導絲系統的日益普及正在改變ERCP手術的操作方式。這些系統使醫生能夠更好地控制手術過程，提高手術效率，同時減少插管和器械更換過程中對助手的需求。

雖然短導絲系統比傳統的長導絲系統更昂貴，但其臨床和操作優勢足以證明其成本合理。更短的手術時間提高了手術效率，減少了麻醉暴露，從而加速了其在醫院和門診內視鏡檢查中的應用。因此，短導絲系統有助於提高平均售價和整體收入。

醫生熟悉情況和培訓

隨著內視鏡醫師在治療性ERCP方面經驗和訓練的積累，該手術的可靠性正在提高。醫師技能的提升直接轉化為每位醫師手術量的增加。醫學協會和器械製造商正在擴大培訓項目，以提高醫師在高級ERCP技術（例如括約肌切開術、支架置入術和體外碎石術）方面的熟練程度。

這一趨勢在新興市場尤其重要，因為在這些市場，獲得培訓和透視設備的機會越來越多，合格的醫療保健專業人員數量也隨之增加，他們可以安全有效地進行 ERCP。

市場限制

套管市場下滑

內視鏡逆行性胰膽管攝影術（ERCP）套管正逐漸被括約肌置入術所取代。套管曾是標準的介入工具，但隨著更有效率的替代方案的出現，其市佔率正在不斷下降。因此，近年來套管的銷售量停滯不前，平均售價也有所下降。為了保持競爭力，製造商紛紛降低價格，限制了市場整體成長。

預計這種結構性變化將持續到完全消除插管為止，進一步鞏固括約肌引導方法的優越性。

ERCP診斷應用減少

近年來，由於對手術風險的擔憂，ERCP 的診斷應用已大幅下降。診斷性 ERCP 有發生併發症的風險，雖然風險較小，但仍不容忽視，併發症包括胰臟炎、感染疾病和出血。

磁振造影胰造影(MRCP) 和超音波內視鏡 (EUS) 等非侵入性替代方法的出現，為臨床醫生提供了避免這些風險的有效影像選擇，從而導致診斷性 ERCP 的數量下降，其用途也轉向治療性適應症。

雖然這種轉變促進了括約肌切開器和支架等治療設備的發展，但也限制了整體手術的擴張，並限制了某些地區的市場成長潛力。

價格競爭

激烈的價格競爭正在抑制ERCP多個區隔市場的價值成長。特別是膽道和胰管支架市場，正面臨來自韓國和中國低成本製造商日益激烈的競爭。這些製造商透過提供品質相當但價格更低的支架，在歐洲等對成本高度敏感的市場中不斷擴大市場佔有率。

雖然這些壓力不如其他內視鏡市場（尤其是支架和套管類別）那麼嚴重，但它們仍然對平均售價施加下行壓力，並限制收入成長。

目標市場和數據範圍

定量範圍

市場規模、佔有率和預測

成長率、銷售量、平均售價

定性範圍

市場成長趨勢與限制因素

競爭對手分析與SWOT分析

併購、公司簡介、產品系列

FDA召回和顛覆性技術分析

影響需求的疾病和手術趨勢概述

時期

• 基準年：2025年
• 預測：2026-2032年
• 歷史資料：2022-2024年

數據來源

對內視鏡醫師和市場高層的初步調查、監管文件、政府和醫院資料、進出口資料庫、iData Research內部資料庫

方法注記

收入模型為銷售量乘以平均售價，透過流程和使用率數據檢驗，並與區域替代和成長假設進行配對。

目標市場及區隔

• 內視鏡逆行性胰造影（ERCP）器材市場－進一步區隔如下：

括約肌內寄生蟲

膽結石取出球囊

膽管結石取出籃

膽道擴張球囊

膽道和胰管支架

膽結石清除器

ERCP導管導引線

ERCP套管

競爭分析

波士頓科學公司是ERCP器材市場的全球領導企業。自2015年收購Xlumena及其AXIOS覆膜金屬支架以來，該公司在治療應用領域實現了強勁成長。這些支架專為在超音波內視鏡引導下經胃或經十二指腸引流有症狀的胰臟假性囊腫和壁壞死而設計。憑藉其廣泛的分銷網路和成熟的品牌知名度，波士頓科學公司在大多數ERCP產品類別中佔領先地位。

奧林巴斯公司憑藉其V-System短導絲平台已在市場中站穩腳跟，並獲得了越來越多轉向短導絲平台的醫生的支持。儘管進入ERCP市場較晚，奧林巴斯正利用其內視鏡產品組合迅速擴大市場佔有率，尤其是在括約肌切開刀領域。

庫克醫療是ERCP領域產品線最豐富的競爭對手之一，提供包括導管導引線、括約肌切開器和體外碎石器在內的全系列產品。庫克醫療以其長期穩定的臨床合作關係和可靠的設備性能而享有盛譽。括約肌切開器和導管導引線業務的成長進一步鞏固了其作為全球領先供應商的地位。

ERCP 市場仍然保持中等集中度，這三家公司佔了全球市場佔有率的大部分，而其他區域製造商則在特定的區隔市場和地區，尤其是在亞太地區和拉丁美洲，佔了一席之地。

科技與臨床趨勢

短導線系統正逐漸取代長導線技術，進而提高手術控制水平，減少對輔助人員的依賴。

隨著醫院越來越重視感染預防和工作流程效率，一次性括約肌切開器和插管裝置的使用率正在不斷提高。

藥物釋放型支架和管腔黏附支架使得以前需要手術才能進行的先進治療性介入成為可能。

ERCP手術室中數位影像技術的整合提高了可視化效果和手術準確性。

體外震波碎石設備不斷發展，能量傳遞系統不斷改進，縮短了治療時間，提高了碎石效率。

透過模擬和指導計劃擴大培訓範圍，正在提高全球獲得先進 ERCP 手術的機會。

地區

本期內容涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

調查方法附錄與簡稱

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

經內視鏡逆行性膽胰管攝影術設備市場

• 摘要整理
  • 全球內經內視鏡逆行性膽胰管攝影術系統市場概覽
  • 競爭分析
  • 流程分段
  • 市場區隔
  • 目標區域
• 介紹
• 手術次數
• 市場概覽
  • 按區隔市場
  • 按地區
• 市場分析與預測
  • 經內視鏡逆行性膽胰管攝影術（ERCP）設備市場整體狀況
  • 括約肌切開刀市場
  • 膽結石移除氣球市場
  • 膽結石清除籃子市場
  • 膽道擴張球囊市場
  • 膽道和胰管支架市場
  • 膽道碎石機市場
  • ERCP導管導引線市場
  • ERCP套管市場
• 推動和阻礙因素
• 競爭市佔率分析

簡稱

The global endoscopic retrograde cholangiopancreatography (ERCP) device market was valued at over $1.9 billion in 2025. The market is projected to grow at a compound annual growth rate (CAGR) of 5.6%, reaching over $2.8 billion by 2032.

This report covers sphincterotomes, biliary stone removal balloons, biliary stone removal baskets, biliary dilation balloons, biliary and pancreatic stents, biliary lithotripters, ERCP guidewires, and ERCP cannulas.

It quantifies unit sales, average selling prices (ASPs), market values, and growth rates, and includes company shares, market drivers and limiters, recent mergers and acquisitions, and technology trends. The analysis incorporates historical data from 2022 to 2024 and forecasts through 2032.

The scope reflects how healthcare providers are adopting minimally invasive, therapeutic ERCP techniques and how ongoing product innovation, particularly short-wire systems and lumen-apposing stents, is improving procedural efficiency and patient outcomes.

Market Overview

Endoscopic retrograde cholangiopancreatography (ERCP) is a specialized endoscopic procedure used to diagnose and treat conditions of the biliary and pancreatic ducts. It combines endoscopic and fluoroscopic imaging to enable interventions such as sphincterotomy, stone extraction, and stent placement.

Over the past decade, the role of ERCP has evolved from a primarily diagnostic tool to a therapeutic intervention, supported by major advances in device design and procedural technique. This transformation has expanded the addressable market for ERCP devices and positioned the field as a cornerstone of minimally invasive gastrointestinal care.

Market growth is being driven by increasing procedure volumes in both developed and emerging regions. The rising global incidence of biliary obstruction, gallstones, and pancreatitis is fueling demand for ERCP interventions. As populations age and chronic liver diseases become more prevalent, procedure frequency continues to rise.

Technology innovation has been especially impactful in improving physician control and reducing complication rates. The introduction of short-wire systems allows for faster cannulation, enhanced device exchange, and more efficient workflow. These systems are now regarded as the new procedural standard in many high-volume centers.

Drug-eluting and lumen-apposing stent technologies are also expanding the therapeutic capabilities of ERCP, enabling the management of complex indications such as pancreatic fluid collections and walled-off necrosis under endoscopic ultrasound (EUS) guidance.

At the same time, certain segments such as ERCP cannulas are gradually being replaced by more advanced device types like sphincterotomes, limiting growth in specific categories. Despite these internal shifts, the ERCP device market remains positioned for sustained expansion through the next decade, reflecting both strong procedural momentum and the integration of therapeutic endoscopy into routine care.

Market Drivers

Sphincterotome Market

The shift toward therapeutic ERCP is a primary growth driver for the global market. As procedures increasingly focus on intervention rather than diagnosis, sphincterotomes are seeing rising demand. This segment represents one of the largest portions of the ERCP device market and will continue to influence overall growth through 2032.

Advancements in sphincterotome design, such as improved wire control and compatibility with short-wire systems, are further expanding utilization. As hospitals transition toward single-use accessories to reduce infection risk, this category's contribution to overall market value is expected to strengthen.

Short-Wire Systems

The increasing use of short-wire systems is reshaping how ERCP procedures are performed. These systems provide physicians with greater procedural control and efficiency while reducing the need for an assistant during cannulation and device exchange.

Short-wire configurations are more expensive than traditional long-wire systems but offer clinical and operational advantages that justify the premium. Adoption is accelerating in both hospital and ambulatory endoscopy settings, where shorter procedure times improve throughput and reduce anesthesia exposure. As a result, short-wire systems are contributing to rising ASPs and overall revenue growth.

Physician Familiarity and Training

As endoscopists gain more experience and training in therapeutic ERCP, procedural confidence is improving. The rise in physician familiarity has directly translated into higher case volumes per practitioner. Medical societies and device manufacturers are expanding training programs, increasing comfort with advanced ERCP techniques such as sphincterotomy, stenting, and lithotripsy.

These trends are particularly important in emerging markets, where expanded access to training and fluoroscopy equipment is helping to increase the number of qualified providers capable of performing ERCP safely and effectively.

Market Limiters

Cannula Market Decline

The ERCP cannula segment is being steadily replaced by sphincterotome-based techniques. Cannulas once represented a standard access tool but are now losing share as more efficient alternatives become the norm. As a result, unit sales have stagnated and average selling prices have declined for several years. Manufacturers have reduced pricing to remain competitive, suppressing total market value growth.

This structural change is expected to continue until cannulas are fully phased out, reinforcing the dominance of sphincterotome-guided approaches.

Decline in Diagnostic Use of ERCP

The diagnostic application of ERCP has fallen sharply in recent years due to concerns over procedural risk. Diagnostic ERCP carries a small but significant risk of complications, including pancreatitis, infection, and bleeding.

The emergence of non-invasive alternatives such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) has provided clinicians with effective imaging options that avoid these risks. As a result, diagnostic ERCP volumes have declined, shifting utilization toward therapeutic indications.

While this transition supports the growth of therapeutic devices like sphincterotomes and stents, it limits overall procedure expansion and caps market growth potential in some regions.

Price Competition

Competitive pricing pressures are moderating value growth in several ERCP subsegments. In particular, biliary and pancreatic stent markets have seen increasing competition from lower-cost manufacturers in South Korea and China. These suppliers have captured share in cost-sensitive markets such as Europe by offering stents with comparable quality at reduced prices.

Although these pressures are less severe than in other endoscopy markets, they continue to apply downward pressure on ASPs and restrict revenue growth, particularly in the stent and cannula categories.

Market Coverage and Data Scope

Quantitative Coverage

Market size, shares, and forecasts

Growth rates, units sold, and average selling prices

Qualitative Coverage

Market growth trends and limiters

Competitive analysis and SWOT for top competitors

Mergers and acquisitions, company profiles, and product portfolios

FDA recalls and disruptive technology analysis

Disease overview and procedure trends impacting demand

Time Frame

• Base year: 2025
• Forecasts: 2026-2032
• Historical data: 2022-2024

Data Sources

Primary interviews with endoscopists and market executives, regulatory filings, government and hospital data, import and export databases, and iData Research's internal database.

Method Note

Revenue is modeled from units multiplied by ASP, validated with procedural and utilization data and cross-checked with regional replacement and growth assumptions.

Markets Covered and Segmentation

• Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market - Further Segmented Into:

Sphincterotome

Biliary Stone Removal Balloon

Biliary Stone Removal Basket

Biliary Dilation Balloon

Biliary and Pancreatic Stent

Biliary Lithotripter

ERCP Guidewire

ERCP Cannula

Competitive Analysis

Boston Scientific is the dominant global competitor in the ERCP device market. Since acquiring Xlumena and its AXIOS lumen-apposing covered-metal stent in 2015, the company has achieved strong growth in therapeutic applications. These stents are designed for transgastric or transduodenal drainage of symptomatic pancreatic pseudocysts and walled-off necrosis under EUS guidance. Boston Scientific's broad distribution network and established brand recognition support its leadership position across most ERCP product segments.

Olympus Corporation has established a strong foothold through its V-System short-wire platform, which has gained traction among physicians transitioning to short-wire procedures. Although a later entrant into the ERCP market, Olympus has leveraged its endoscopy portfolio to rapidly increase its market share, especially within the sphincterotome category.

Cook Medical remains one of the most diversified competitors in the ERCP space, offering a complete portfolio that includes guidewires, sphincterotomes, and lithotripters. The company benefits from long-standing clinical relationships and a reputation for reliable device performance. Growth within its sphincterotome and guidewire segments continues to reinforce its position as a key global supplier.

The ERCP market remains moderately concentrated, with these three companies controlling a majority of global share. Other regional manufacturers participate in specific niches or geographies, particularly in Asia-Pacific and Latin America.

Technology and Practice Trends

Short-wire systems are replacing long-wire techniques, improving procedural control and reducing reliance on assistant staff.

Single-use sphincterotomes and cannulation devices are gaining adoption as hospitals focus on infection prevention and workflow efficiency.

Drug-eluting and lumen-apposing stents are enabling advanced therapeutic interventions previously requiring surgery.

Digital imaging integration within ERCP suites is enhancing visualization and procedural accuracy.

Lithotripsy devices continue to evolve with improved energy delivery systems that shorten treatment times and improve fragmentation efficiency.

Training expansion through simulation and mentorship programs is increasing global access to advanced ERCP procedures.

Geography

This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global ERCP device market

How will short-wire systems and therapeutic ERCP adoption influence market growth through 2032

What are the key risks and constraints, including price competition and the decline of diagnostic ERCP

Which technological advancements are driving product differentiation in stents, sphincterotomes, and guidewires

How do leading manufacturers Boston Scientific, Olympus, and Cook Medical compete across product categories and regions

What training and infrastructure trends are shaping adoption in emerging markets

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market Report from iData Research answers these questions with procedure-aware models, pricing data, and company share analysis. Use it to quantify demand, support strategic planning, benchmark product performance, and identify future growth opportunities.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Endoscopic Retrograde Cholangiopancreatography Device Market

• 7.1 Executive Summary
  • 7.1.1 Global Endoscopic Retrograde Cholangiopancreatography Device Market Overview
  • 7.1.2 Competitive Analysis
  • 7.1.3 Procedure Segmentation
  • 7.1.4 Market Segmentation
  • 7.1.5 Regions Included
• 7.2 Introduction
• 7.3 Procedure Numbers
• 7.4 Market Overview
  • 7.4.1 By Segment
  • 7.4.2 By Region
• 7.5 Market Analysis And Forecast
  • 7.5.1 Total Endoscopic Retrograde Cholangiopancreatography (Ercp) Device Market
  • 7.5.2 Sphincterotome Market
  • 7.5.3 Biliary Stone Removal Balloon Market
  • 7.5.4 Biliary Stone Removal Basket Market
  • 7.5.5 Biliary Dilation Balloon Market
  • 7.5.6 Biliary And Pancreatic Stent Market
    • 7.5.6.1 Covered-Metal Biliary And Pancreatic Stent Market
    • 7.5.6.2 Bare-Metal Biliary And Pancreatic Stent Market
    • 7.5.6.3 Plastic Biliary And Pancreatic Stent Market
  • 7.5.7 Biliary Lithotripter Market
  • 7.5.8 Ercp Guidewire Market
  • 7.5.9 Ercp Cannula Market
• 7.6 Drivers And Limiters
  • 7.6.1 Market Drivers
  • 7.6.2 Market Limiters
• 7.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 7-1: Endoscopic Retrograde Cholangiopancreatography Device Market, Global, 2025 & 2032
• Chart 7-2: Endoscopic Retrograde Cholangiopancreatography Device Procedures, Global, 2025
• Chart 7-3: ERCP Procedures by Region, Global, 2022 - 2032
• Chart 7-4: Endoscopic Retrograde Cholangiopancreatography Device Market by Segment, Global, 2022 - 2032
• Chart 7-5: Endoscopic Retrograde Cholangiopancreatography Device Market by Region, Global, 2022 - 2032
• Chart 7-6: Leading Competitors, Endoscopic Retrograde Cholangiopancreatography Device Market, Global, 2025

LIST OF FIGURES

• Figure 7-1: Endoscopic Retrograde Cholangiopancreatography Device Procedure Segmentation
• Figure 7-2: Endoscopic Retrograde Cholangiopancreatography Device Market Segmentation
• Figure 7-3: Endoscopic Retrograde Cholangiopancreatography Device Regions Covered, Global (1 of 2)
• Figure 7-4: Endoscopic Retrograde Cholangiopancreatography Device Regions Covered, Global (2 of 2)
• Figure 7-5: ERCP Procedures by Region, Global, 2022 - 2032
• Figure 7-6: ERCP Procedures by Country, North America, 2022 - 2032
• Figure 7-7: ERCP Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 7-8: ERCP Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 7-9: ERCP Procedures by Country, Western Europe, 2022 - 2032
• Figure 7-10: ERCP Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 7-11: ERCP Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 7-12: ERCP Procedures by Country, Middle East, 2022 - 2032
• Figure 7-13: ERCP Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 7-14: ERCP Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 7-15: ERCP Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 7-16: ERCP Procedures by Country, Africa, 2022 - 2032
• Figure 7-17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 7-18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 7-19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032
• Figure 7-20: Units Sold by Region, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032
• Figure 7-21: Average Selling Price by Region, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032 (US$)
• Figure 7-22: Market Value by Region, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032 (US$M)
• Figure 7-23: Sphincterotome Market, Global, 2022 - 2032
• Figure 7-24: Units Sold by Region, Sphincterotome Market, Global, 2022 - 2032
• Figure 7-25: Average Selling Price by Region, Sphincterotome Market, Global, 2022 - 2032 (US$)
• Figure 7-26: Market Value by Region, Sphincterotome Market, Global, 2022 - 2032 (US$M)
• Figure 7-27: Biliary Stone Removal Balloon Market, Global, 2022 - 2032
• Figure 7-28: Units Sold by Region, Biliary Stone Removal Balloon Market, Global, 2022 - 2032
• Figure 7-29: Average Selling Price by Region, Biliary Stone Removal Balloon Market, Global, 2022 - 2032 (US$)
• Figure 7-30: Market Value by Region, Biliary Stone Removal Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 7-31: Biliary Stone Removal Basket Market, Global, 2022 - 2032
• Figure 7-32: Units Sold by Region, Biliary Stone Removal Basket Market, Global, 2022 - 2032
• Figure 7-33: Average Selling Price by Region, Biliary Stone Removal Basket Market, Global, 2022 - 2032 (US$)
• Figure 7-34: Market Value by Region, Biliary Stone Removal Basket Market, Global, 2022 - 2032 (US$M)
• Figure 7-35: Biliary Dilation Balloon Market, Global, 2022 - 2032
• Figure 7-36: Units Sold by Region, Biliary Dilation Balloon Market, Global, 2022 - 2032
• Figure 7-37: Average Selling Price by Region, Biliary Dilation Balloon Market, Global, 2022 - 2032(US$)
• Figure 7-38: Market Value by Region, Biliary Dilation Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 7-39: Biliary and Pancreatic Stent Market by Segment, Global, 2022- 2032 (US$M)
• Figure 7-40: Total Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-41: Units Sold by Region, Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-42: Average Selling Price by Region, Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-43: Market Value by Region, Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 7-44: Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2031
• Figure 7-45: Units Sold by Region, Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-46: Average Selling Price by Region, Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-47: Market Value by Region, Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2031 (US$M)
• Figure 7-48: Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-49: Units Sold by Region, Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-50: Average Selling Price by Region, Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-51: Market Value by Region, Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 7-52: Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-53: Units Sold by Region, Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-54: Average Selling Price by Region, Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-55: Market Value by Region, Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 7-56: Biliary Lithotripter Market, Global, 2022 - 2032
• Figure 7-57: Units Sold by Region, Biliary Lithotripter Market, Global, 2022 - 2032
• Figure 7-58: Average Selling Price by Region, Biliary Lithotripter Market, Global, 2022 - 2032 (US$)
• Figure 7-59: Market Value by Region, Biliary Lithotripter Market, Global, 2022 - 2031 (US$M)
• Figure 7-60: ERCP Guidewire Market, Global, 2022 - 2032
• Figure 7-61: Units Sold by Region, ERCP Guidewire Market, Global, 2022 - 2032
• Figure 7-62: Average Selling Price by Region, ERCP Guidewire Market, Global, 2022 - 2032 (US$)
• Figure 7-63: Market Value by Region, ERCP Guidewire Market, Global, 2022 - 2032 (US$M)
• Figure 7-64: ERCP Cannula Market, Global, 2022 - 2032
• Figure 7-65: Units Sold by Region, ERCP Cannula Market, Global, 2022 - 2032
• Figure 7-66: Average Selling Price by Region, ERCP Cannula Market, Global, 2022 - 2032 (US$)
• Figure 7-67: Market Value by Region, ERCP Cannula Market, Global, 2022 - 2032 (US$M)
• Figure 7-68: Leading Competitors, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2025